ZA945752B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA945752B
ZA945752B ZA945752A ZA945752A ZA945752B ZA 945752 B ZA945752 B ZA 945752B ZA 945752 A ZA945752 A ZA 945752A ZA 945752 A ZA945752 A ZA 945752A ZA 945752 B ZA945752 B ZA 945752B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA945752A
Other languages
English (en)
Inventor
Ferenc Ender
Laszlo Rosivall
Jozsef Furesz
Katalin Schweitzer
Original Assignee
Chinoin Gyogyszer Es Vegyeesze
Termekek Gyara Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeesze, Termekek Gyara Rt filed Critical Chinoin Gyogyszer Es Vegyeesze
Publication of ZA945752B publication Critical patent/ZA945752B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA945752A 1993-08-02 1994-08-02 Pharmaceutical composition ZA945752B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9302229A HUT68560A (en) 1993-08-02 1993-08-02 The use of xantine derivatives for promotion of healing of operative lesions

Publications (1)

Publication Number Publication Date
ZA945752B true ZA945752B (en) 1995-10-25

Family

ID=10983853

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA945752A ZA945752B (en) 1993-08-02 1994-08-02 Pharmaceutical composition

Country Status (11)

Country Link
US (1) US5516778A (fr)
EP (1) EP0640342A3 (fr)
JP (1) JPH07145059A (fr)
KR (1) KR950005307A (fr)
CA (1) CA2129274A1 (fr)
CZ (1) CZ185394A3 (fr)
HU (1) HUT68560A (fr)
LV (1) LV10579B (fr)
RU (1) RU94028283A (fr)
SK (1) SK92194A3 (fr)
ZA (1) ZA945752B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436425B1 (en) 1988-11-16 2002-08-20 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
AU1526497A (en) * 1995-10-06 1998-07-31 Mdv Technologies, Inc. Method and non-gelling composition for inhibiting post-surgical adhesions
KR20100121527A (ko) 2008-02-29 2010-11-17 콘서트 파마슈티컬즈, 인크. 치환된 잔틴 유도체
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US20140296263A1 (en) 2011-07-19 2014-10-02 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
CN104364255A (zh) 2012-04-13 2015-02-18 康塞特医药品有限公司 取代的黄嘌呤衍生物
WO2015160913A1 (fr) 2014-04-18 2015-10-22 Concert Pharmaceuticals, Inc. Méthodes de traitement de l'hyperglycémie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU197207B (en) * 1985-12-04 1989-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient

Also Published As

Publication number Publication date
RU94028283A (ru) 1996-08-27
HUT68560A (en) 1995-04-27
US5516778A (en) 1996-05-14
LV10579A (lv) 1995-04-20
KR950005307A (ko) 1995-03-20
CA2129274A1 (fr) 1995-02-03
HU9302229D0 (en) 1993-10-28
JPH07145059A (ja) 1995-06-06
EP0640342A2 (fr) 1995-03-01
LV10579B (en) 1995-10-20
EP0640342A3 (fr) 1995-04-19
CZ185394A3 (en) 1995-02-15
SK92194A3 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
HU9402974D0 (en) Pharmaceutical composition
ZA946262B (en) Pharmaceutical compositions
GB9317610D0 (en) Pharmaceutical compositions
GB9316580D0 (en) Pharmaceutical composition
AP9200356A0 (en) Pharmaceutical composition
GB2272375B (en) Pharmaceutical composition
PL314036A1 (en) Pharmaceutical composition
CA2100836A1 (fr) Composition pharmaceutique
GB9317504D0 (en) Pharmaceutical compositions
GB9221707D0 (en) Pharmaceutical composition
GB9318880D0 (en) Pharmaceutical composition
HU9401771D0 (en) Pharmaceutical compositions cintaining ipsapiron
ZA947878B (en) Pharmaceutical compositions
GB9314564D0 (en) Pharmaceutical composition
ZA935269B (en) Pharmaceutical composition
GB9314709D0 (en) Pharmaceutical composition
HU9303386D0 (en) Pharmaceutical composition
GB9320688D0 (en) Pharmaceutical composition
GB9321671D0 (en) Pharmaceutical composition
ZA947913B (en) Pharmaceutical composition
HU9303511D0 (en) Pharmaceutical composition
GB9417021D0 (en) Pharmaceutical composition
GB9308849D0 (en) Pharmaceutical composition
GB9318350D0 (en) Pharmaceutical composition
GB9316849D0 (en) Pharmaceutical compositions